AC
AGN

Anavon Capital’s Allergan plc AGN Stock Holding History

Anavon Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$20.1M Buy
+105,690
New +$19.4M 18.31% 1
2016
Q4 		$18.6M Buy
+88,480
New +$18.3M 17.55% 1

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Anavon Capital's AGN Position: Q3 2018 in Review

Anavon Capital opened a new position in Allergan plc (AGN) in Q3 2018: 105,690 shares worth $20.1M. The stake represents 18.31% of the portfolio and ranks #1 among its holdings. This is a return to the name: Anavon Capital previously reported a position in AGN as recently as Q4 2016.

Anavon Capital first reported a position in AGN in Q4 2016 and has held it in 2 quarters since. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Anavon Capital held 105,690 shares of Allergan plc worth $20.1M as of Q3 2018.
  • Allergan plc was a new Anavon Capital position in Q3 2018.
  • Allergan plc made up 18.31% of Anavon Capital's portfolio in Q3 2018, its #1 holding.
  • Anavon Capital first reported a position in Allergan plc in Q4 2016 and has held it in 2 quarters since.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Anavon Capital's 13F filing for Q3 2018, filed 7 Nov 2018.